Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • baohua100
    Senior Member
    • Jun 2008
    • 103

    #1

    RPKM for alternative splicing genes?

    When calculate a PRKM for a gene locus

    R=109C/NL
    where C is the number of mappable reads that fell onto the gene’s exons, N is the total number of mappable reads in the experiment, and L is the sum of the exons in base pairs.

    for genes with alternative splicing, like a intron retain, how to determin the L ? is this intron count into the L ?
  • juan
    Member
    • Aug 2009
    • 14

    #2
    L is the sum of bases for the gene, not the exon, right?

    RPKM does not account for splicing, nor does it distinguish between transcript isoforms.

    I would include the intron in the L.

    Comment

    • steven
      Senior Member
      • Aug 2009
      • 269

      #3
      I would suggest to "project" or "collapse" all the exons onto the genomic sequence and work in genomic space. Then your C will be the number of mappable reads that fall in an exonic region (of one of the transcripts of your gene), and L the total exonic space of the gene (number of genomic positions that are found in a mature transcript, not the "sum of the exons"). Like this, overlapping parts of exons from different transcripts are not counted several times. Also, transcribed areas that are alternatively retained into splice products (like your "retained intron") will be part of L.

      AFAIK, nothing has been published yet regarding relative quantification of transcript variants from alternative splicing. Does anyone have more info?

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      33 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      23 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      41 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      45 views
      0 reactions
      Last Post SEQadmin2  
      Working...